99mTc-CN7DG: A Highly Expected SPECT Imaging Agent of Cancer with Satisfactory Tumor Uptake and Tumor-to-Nontarget Ratios-Reference-Cited by-同舟云学术

99mTc-CN7DG: A Highly Expected SPECT Imaging Agent of Cancer with Satisfactory Tumor Uptake and Tumor-to-Nontarget Ratios

Published:2021-02-15 Issue:3 Volume:18 Page:1356-1363
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Gan Qianqian¹,Zhang Xuran¹,Ruan Qing¹,Fang Si’an¹,Zhang Junbo¹^ORCID

Affiliation:

1. Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, People’s Republic of China

Funder

National Natural Science Foundation of China

the project of Beijing Municipal Science and Technology Commission

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.0c01177

Reference23 articles.

1. Role of 18F-FDG PET in Assessment of Response in Non–Small Cell Lung Cancer

2. FDG for Therapy of Metabolically Active Tumors

3. Radiolabeled Glucose Derivatives for Tumor Imaging Using SPECT and PET

4. Current Status of Nuclear Medicine Practice in Latin America and the Caribbean

5. Advances in clinical molecular imaging instrumentation

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel ^99mTc-Labeled Mannose Derivative as a Highly Promising Single Photon Emission Computed Tomography Probe for Tumor Imaging;Journal of Medicinal Chemistry;2024-07-26

2. The Preparation and Execution of Exploratory Human Studies on Novel ^99mTc-Labeled Glucosamine Derivatives Containing Different Phenyl Isonitriles as Promising Tumor Imaging Agents;ACS Pharmacology & Translational Science;2023-10-11

3. Advantages of 99mTc-CNDG SPECT/CT over Enhanced CT in the Staging of Non-Small Cell Lung Cancer;2023-06-27

4. Preparation and Bioevaluation of a Novel 99mTc-Labeled Glucose Derivative Containing Cyclohexane as a Promising Tumor Imaging Agent;Pharmaceuticals;2023-04-18

5. Phase I Clinical Trial Using [99mTc]Tc-1-thio-D-glucose for Diagnosis of Lymphoma Patients;Pharmaceutics;2022-06-15